Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit

Chemoprevention of prostate cancer by second-generation selenium compounds in reference to selenomethionine holds strong promise to deal with the disease at the root. Here we used the transgenic adenocarcinoma mouse prostate (TRAMP) model to establish the efficacy of methylseleninic acid (MSeA) and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wang, Lei, Bonorden, Melissa J. L., Li, Guang-xun, Lee, Hyo-Jeong, Hu, Hongbo, Zhang, Yong, Liao, Joshua D., Cleary, Margot P., Lü, Junxuan
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2822708/
https://ncbi.nlm.nih.gov/pubmed/19401524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0173
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars